GlaxoSmithKline Consumer Healthcare Pakistan Limited announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was PKR 5,281.070 million compared to PKR 3,913.657 million a year ago. Operating income was PKR 446.597 million compared to PKR 402.583 million a year ago. Net income was PKR 295.959 million compared to PKR 279.524 million a year ago. Basic earnings per share from continuing operations was PKR 2.53 compared to PKR 2.39 a year ago. For the nine months, sales was PKR 14,489.452 million compared to PKR 11,812.260 million a year ago. Operating income was PKR 1,441.384 million compared to PKR 1,401.772 million a year ago. Net income was PKR 979.557 million compared to PKR 888.342 million a year ago. Basic earnings per share from continuing operations was PKR 8.37 compared to PKR 7.59 a year ago.